ABSENCE OF ANXIOLYTIC EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS

被引:4
|
作者
DEANGELIS, L
机构
[1] Institute of Pharmacology, School of Medicine, University of Trieste, Trieste
关键词
NIFEDIPINE; NICARDIPINE; +/-VERAPAMIL; PHENOBARBITONE; +/-PROPANALOL;
D O I
10.1002/ddr.430230409
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The potential anxiolytic effects of some calcium channel antagonists (nifedipine, nicardipine, and +/- verapamil) were investigated in the elevated plus-maze test in mice. The acute effects of the above-mentioned drugs were compared with those of phenobarbitone and +/- propanolol. Results showed that control mice spent less time in the open than in the closed arms, reflecting increased anxiety. Both phenobarbitone (20 mg/kg i.p.) and +/- propanolol (5 mg/kg i.p.) increased the percentage of entries into open arms as well as the time spent on the open arms. Nifedipine (2 and 4 mg/kg i.p.), nicardipine (0.5 and 1.0 mg/kg i.p.), and +/- verapamil (5 and 10 mg/kg i.p.) failed to alter significantly the behavior of mice. In summary, although there have been some reports based on other tests that calcium antagonists may have potential anxiolytic properties, this conclusion has not been supported by our results from the elevated plus-maze test.
引用
收藏
页码:359 / 364
页数:6
相关论文
共 50 条
  • [21] Calcium-channel antagonists in cardiovascular disease
    Holdright, DR
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1997, 57 (11) : 552 - 556
  • [22] DIZZINESS IN THE ELDERLY AND CALCIUM-CHANNEL ANTAGONISTS
    LEJEUNNE, C
    HUGUES, FC
    MUNERA, Y
    OZANNE, H
    BIOMEDICINE & PHARMACOTHERAPY, 1991, 45 (01) : 33 - 36
  • [23] CALCIUM-CHANNEL ANTAGONISTS IN THE TREATMENT OF ASTHMA
    FISH, JE
    JOURNAL OF ASTHMA, 1984, 21 (06) : 407 - 418
  • [24] CALCIUM-CHANNEL ANTAGONISTS FOR PREVENTION OF ATHEROSCLEROSIS
    BORCHERDING, SM
    MEEVES, SG
    KLUTMAN, NE
    HOWARD, PA
    ANNALS OF PHARMACOTHERAPY, 1993, 27 (01) : 61 - 67
  • [25] RECENT DEVELOPMENT IN CALCIUM-CHANNEL ANTAGONISTS
    TRIGGLE, DJ
    JANIS, RA
    MAGNESIUM, 1989, 8 (5-6) : 213 - 222
  • [26] RECEPTORS FOR CALCIUM-CHANNEL ANTAGONISTS IN CARDIOMYOPATHY
    BAZAN, E
    SCHWARTZ, A
    GARDNER, S
    WELLS, JW
    SOLE, MJ
    JOHNSON, CL
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 852 - 852
  • [27] EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS ON TARDIVE-DYSKINESIA AND PSYCHOSIS
    ADLER, L
    DUNCAN, E
    REITER, S
    ANGRIST, B
    PESELOW, E
    ROTROSEN, J
    PSYCHOPHARMACOLOGY BULLETIN, 1988, 24 (03) : 421 - 425
  • [28] EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS ON THE NA+-CA+ EXCHANGE
    JUHASZ, O
    RUSCAK, M
    ORLICKY, J
    ZACHAR, J
    PHYSIOLOGIA BOHEMOSLOVACA, 1985, 34 (05): : 430 - 430
  • [29] EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS AND OTHER ANTIHYPERTENSIVE DRUGS ON ATHEROGENESIS
    CHOBANIAN, A
    JOURNAL OF HYPERTENSION, 1987, 5 : S43 - S48
  • [30] HEPATOPROTECTIVE EFFECTS OF DIHYDROPYRIDINE CALCIUM-ANTAGONISTS ARE NOT RELATED TO CALCIUM-CHANNEL BLOCK
    IIDA, Y
    TAKANASHI, H
    KAMISAKA, K
    UESUGI, T
    HEPATOLOGY, 1988, 8 (05) : 1378 - 1378